Report Description of the EU Respiratory Devices Market Analysis

Research Scope and Assumption

• The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)


• The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis


• We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses


• All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis


• Inflation has not been accounted for in order to estimate and forecast the market


• Numbers may not add up due to rounding off

Reason to buy the report:

• Facilitate decision-making based on strong current and forecast data for EU Respiratory Devices Market Analysis


• Develop strategies based on the latest regulatory framework


• Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market


• Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Respiratory Devices Market Analysis


• Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders


• To strategically profile key players and comprehensively analyze their market shares and core competencies


• We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Respiratory Devices Market Analysis Executive Summary

Respiratory care devices are the type of instruments which are used to monitor, treat and diagnose respiratory diseases such as pneumonia, asthma, tuberculosis and chronic obstructive pulmonary disease (COPD). These instruments are used to improve or enhance pulmonary function and oxygenation of the lung. Inhalers include ventilators, PAP devices, nebulizers, and oxygen concentrators.

Market Size and Key Findings

The EU Respiratory Devices Market Analysis size stood at around USD 5.11 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 9.47% during the forecast period.

The Respiratory Devices Market size in Europe was worth USD 5.11 Billion in 2020 and estimated to be growing at a CAGR of 9.47% to reach USD 8.04 Billion by 2028. Respiratory Devices are devices used to support people suffering from respiratory problems and cannot achieve satisfactory oxygen levels to sustain life.



Market Dynamics

Market Growth Drivers Analysis

Extensive growth in the global geriatric population is the vital factor escalating the market growth, also rising urbanization and growing pollution levels, rising preterm birth events, increased prevalence of tobacco smoking, changing lifestyles, rising incidence rate of preterm births and rising outbreak of infectious diseases affecting respiratory system are the major factors among others driving the respiratory care devices market. Moreover, rising demand for home care therapeutic devices, increased growth in developing countries across APAC and Latin America and rising point-of-care diagnostics will further create new opportunities for respiratory care devices market in the forecasted period of 2021-2028.

Market Restraints

Rising unfavorable reimbursement scenario and rising availability of low-cost products from local manufacturers are the major factors among others which will obstruct the market growth, while low awareness and large underdiagnosed and undertreated population, and harmful effects of certain devices on neonates will further challenge the growth of respiratory care devices market in the forecast period mentioned above.

COVID-19 impact on "EU Respiratory Devices Market Analysis

Considering the influence of COVID-19 on the global Ultra-Low Alpha Metals market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

Competitive Landscape

Key Players

Respiratory care devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to respiratory care devices market.

The major players covered in the respiratory care devices market report are Chart Industries, DeVilbiss Healthcare LLC, Drgerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited., GENERAL ELECTRIC, Medtronic, Koninklijke Philips N.V., GlaxoSmithKline plc, ResMed, BD, Hamilton Medical, Masimo, Air Liquide, VYAIRE, Getinge AB, Abbott, 3M, AstraZeneca, MicroAire Surgical Instruments LLC., and Smith & Nephew Inc. among other domestic and regional players. Market share data is available for Europe only. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Products in Pipeline

Respiratory care devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for respiratory care devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the respiratory care devices market. The data is available for historic period 2021 to 2028.

Notable Recent Deals

• In September 2017, Chiesi Farmaceutici completed the clinical study of Tribute with its Trimbow an extra-fine fixed-dose triple combination inhaler. The organization also got the marketing authorization for Trimbow from the European Commission.


• In November 2016, the company acquired Atopix therapeutics limited, the transaction aimed to develop novel treatments for asthma and strengthen the company's asthma portfolio.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The European Respiratory Society (ERS) supports science-based policy and helps to strengthen science by sponsoring research grants for recent graduates and healthcare professionals in their early career stages and doctoral research fellowships.

• Strengthen science, support basic and translational respiratory research projects and ensure the allocation of vital resources for respiratory issues


• Ensure a meaningful and an integrated approach to involving patients throughout the entire cycle of clinical research.


• Promote ethical, transparent and accountable research practices.